Please login to the form below
W2O acquires advertising and medical education agency 21GRAMS
Acquisition adds 150 experts to the W2O team
FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
If approved will become first BCMA targeting drug for myeloma
EU group calls for 'targeted actions' to mitigate impact of Brexit
Committee wants to ensure safe supply of drugs and medical devices
FDA approves Horizon's thyroid eye disease drug ahead of schedule
First FDA-approved treatment for rare autoimmune condition
Presidential hopeful Bernie Sanders criticises BioMarin’s gene therapy price
Vowed to break patent if company goes ahead with proposed price
AZ’s Imfinzi scores orphan drug status in liver cancer
Company is looking to gain approval in the first-line advanced setting
UPDATED: J&J's $8bn Risperdal judgment reduced to $6.8m
Company will still appeal reduced verdict
EU grants conditional approval to Roche's lymphoma drug Polivy
Drug demonstrated a 40% complete response rate in trial
Novartis gets EU approval for multiple sclerosis therapy Mayzent
Offers subgroup of patients an important new treatment option
Q&A: Emma Sergeant
PME interviews president of the DAS Group of Companies in Europe
-
Q&A: Vicky BramhamPME interviews OPEN Health Patient & Brand Communications' managing director, PR
-
Q&A: Steve ClarkPME interviews the director of Redwood Brand Curators
-
J&J wins another label expansion for Darzalex in EuropeMultiple myeloma treatment indicated for early use
-
Immuno-oncology, personalised medicine continues to drive pharma sectorNew GlobalData survey identifies key trends impacting the industry
-
Lilly will aim for one $1bn-$5bn deal per quarter in 2020Company seeks to bolster pipeline with a string of M&A activity
-
J&J pushes to expand Imbruvica label after clinical successEyes the frontline setting in chronic lymphocytic leukaemia
-
FDA delays decision on Intercept's NASH drug by three monthsAction date pushed back to 26 June
-
Communiqué Awards 2020 is now open for entry This year's programme sees the introduction of two new categories
-
Newly-listed BioNTech buys Neon to boost cell therapy assetsGerman biotech has agreed to pay $67m in the deal
Latest appointments
-
Lucid Group names Neil Flash chief commercial officerFlash joins the team from dna Communications
-
New hires at bluebird bio, BioNTech and Provention BioThe latest movers in pharma
-
IGNIFI expands healthcare team with two new hiresCraig Lambert and Rebecca Dargue join the team
-
Christie Anbar appointed global healthcare lead at Ruder FinnAnbar will oversee the agency's entire healthcare business
-
RFA strengthens team with a host of hires and promotions New hires coincide with continued growth
Featured jobs
- Director of Scientific Services, Medical Communications, Six fig...
-
Six figure salary
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Account Director or Senior Account Director
-
Salary TBC
-
Consultant
-
competitive salary
-
Principal Medical Writer
-
£48 - 58, 000 according to skills and experience benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Account Manager– Medical Communications
-
(Negotiable - depending on experience)
-
Vice President
-
Competitive Salary Offered
Subscribe to our email news alerts
- NantKwest rockets on promising pancreatic cancer data
- NantKwest rockets on promising pancreatic cancer data
- Novo Nordisk gets MACE prevention claim for Ozempic in US
- Lilly will aim for one $1bn-$5bn deal per quarter in 2020
- Clovis leapfrogs PARP rivals, filing Rubraca for prostate cancer
- J&J wins another label expansion for Darzalex in Europe
- Lucid Group names Neil Flash chief commercial officer
- New hires at bluebird bio, BioNTech and Provention Bio
- IGNIFI expands healthcare team with two new hires
- W2O acquires advertising and medical education agency 21GRAMS
- FDA fast-tracks GSK’s anti-BCMA drug for multiple myeloma
- EU group calls for 'targeted actions' to mitigate impact of Brexit
PMHub
Nobull Communications
Switched on Creative Communications. With an encyclopedic working knowledge of pharmaceutical industry rules and regulations, we create dynamic, intuitive and...
Latest intelligence
- White Paper for download - Explaining the price of your product
- In this white paper, he breaks down the pricing options available to you, shares stories from his extensive experiences, and talks you through how to better define your pricing, step-by-step....
- OPEN Health expands offering with the launch of a new Learning & Development specialist team
- Enhanced expertise to deliver impactful internal training programmes for healthcare clients...
- The changing nature of approvals – what does the future hold?
- The 2019 CMR International Pharmaceutical R&D Factbook...
Quick links
Infographics
